Maxadilan is a small ( ≈ ≈ ≈ ≈ 7 kDa) protein found in the saliva of sand fly species in the Lutzomyia longipalpis complex, vectors of the parasite causing visceral leishmaniasis, Leishmania chagasi . It is a potent vasodilator and also has immunomodulatory affects. Maxadilan recovered from different sibling species of the Lu. longipalpis complex differ in amino acid content by as much as 23%, however all variants possess equivalent vasodilatory activity. Therefore, the dramatic differences in vasodilatory activity of the saliva from different sibling species is probably due to differences in the amounts of maxadilan in their saliva. This is significant because it has been suggested that maxadilan may influence the pathogenesis of leishmanial infections. In this study we measured the amount of maxadilan messenger RNA (mRNA) per pair of salivary glands from individual sand flies by quantitative reverse transcription polymerase chain reaction (RT-PCR) using a competitive method. We report a method using the gene of interest, in this case maxadilan, amplified by the PCR from genomic DNA, as a competitor in the quantitative RT-PCR, taking advantage of differences in the size of these products due to the presence of an intron. Significant differences in amounts of maxadilan mRNA among colonies from Central and South America are described. We found a strong correlation between the amount of maxadilan mRNA detected in salivary glands of different Lu. longipalpis sibling species and previously described differences in the size of erythemas produced by the bite of these species. Therefore, variation in the amount of mRNA suggests that differences in the vasodilatory properties of saliva among the different sibling species are the result of differences in the amount of maxadilan present in the saliva and not differences in the potency of maxadilan peptide variants. The geographical distribution of species with high or low levels of maxadilan gene expression are concordant with the distribution of atypical cutaneous leishmaniasis resulting from infection with Le. chagasi , lending credence to earlier suggestions that maxadilan may be involved with visceralization of this parasite.
Introduction
Blood-feeding arthropods inject saliva into their vertebrate host while feeding. Saliva functions to facilitate the location of blood vessels and to inhibit host haemostasis, thus enabling the insect to ingest blood unimpeded (Ribeiro, 1987) . The saliva of Lutzomyia longipalpis , the sand fly vector of visceral leishmaniasis in the Neotropics, contains an extremely potent vasodilator, known as maxadilan, which produces a long-lasting erythema at the bite site (Ribeiro et al. , 1986) . The gene encoding maxadilan has been cloned and the maxadilan peptide characterized (Lerner & Shoemaker, 1992) . Mature maxadilan contains sixty-three amino acids and has a molecular mass of 7026 Da. Within the coding region of the maxadilan gene is an 84-bp intron.
Sand fly saliva has immunomodulatory activities in addition to its antihaemostatic properties and there is evidence that Leishmania parasites utilize this activity to facilitate their establishment in the vertebrate host. Titus & Ribeiro (1988) showed that lesions on mice that received injections of Le. major and salivary gland extract (SGE) from the sand fly Lu. longipalpis were substantially more severe than those injected with parasite alone. Theodos et al . (1991) observed a similar effect with Lu. longipalpis and Le. mexicana amazonensis and with Ph. papatasi and Le. major . Mbow et al . (1998) found that the Ph. papatasi SGE-associated exacerbation of lesion development in Le. major infected mice correlated with the inhibition of Th1 cytokines and associated factors, including interferon γ (IFN-γ ), interleukin 12 (IL-12) and inducible nitric oxide synthase. The disease-promoting effect of sand fly saliva has been clearly demonstrated in an ear infection model of Le. major in both susceptible BALB/c and resistant C57BL/6 mice . More importantly, this study indicates that antisaliva antibodies are able to neutralize the ability of saliva to enhance infection, suggesting a potential application of sand fly salivary proteins as vaccine candidates for the control of leishmaniasis. It remains unclear if sand fly saliva plays a role in enhancing dissemination of Leishmania parasites and in the pathogenesis of visceral leishmaniasis, as has been suggested by Warburg et al . (1994) .
At present the individual components in sand fly saliva that are responsible for enhancing Leishmania infections have not been identified. However, maxadilan has been shown to possess immunosuppressant activity in addition to its vasodilatory properties. Maxadilan inhibited T-cell proliferation in murine spleen cells stimulated with either Con A or plate-bound anti-T-cell receptor antibody (Qureshi et al. , 1996) . Moro & Lerner (1997) demonstrated that maxadilan is an agonist of the type I receptor for pituitary adenylate cyclase-activating peptide (PACAP). Soares et al . (1998) recently showed that maxadilan has multiple effects on murine macrophages; it inhibits tumour necrosis factor α (TNF-α ), but induces IL-6 production by the cells. They related these activities to the interaction between maxadilan and the PACAP receptor. Both the vasodilatory and immunosuppressive activities of maxadilan probably derive from its mimicking of PACAP-type neuropeptides. Lanzaro et al . (1993) demonstrated postmating reproductive isolation, in the form of hybrid male sterility, among laboratory populations of Lu. longipalpis , leading them to suggest that the taxon is actually comprised of at least three sibling species that occur in Costa Rica, Colombia and Brazil. This work included the identification of allozymes at several loci that are diagnostic for each sibling species. Subsequent studies of isozyme variation among a large number of field populations throughout the range of the Lu. longipalpis complex supports this conclusion.
In Costa Rica, infections with Le. chagasi most frequently result in a non-ulcerative form of cutaneous leishmaniasis (Zeledon et al. , 1989) , while in South America infections are almost exclusively associated with visceral leishmaniasis (Grimaldi et al. , 1989) . Parasite isolates from cutaneous cases proved indistinguishable from isolates made from visceral infections (Zeledon et al. , 1989; Ponce et al. , 1991) . Interestingly, the bites of Lu. longipalpis females from Costa Rica do not leave long-lasting red erythemas, which are characteristic of Lu. longipalpis from Brazil and Colombia (Warburg et al. , 1994) . A comparison of signal intensity on Western blots of salivary gland lysates from the three species suggests that the saliva of the Costa Rican species contains 10 -40% less maxadilan. These observations led Warburg et al . (1994) to suggest that maxadilan may play a role in visceralization of Le. chagasi . However, the authors point out that the difference may be the result of differential affinity of maxadilan from Costa Rican flies for the antiserum used, which came from maxadilan from Brazilian flies. Indeed, maxadilan from different sibling species differ by as much as 23% in amino acid composition (Lanzaro et al. , 1999) . Despite these differences Lanzaro et al . (1999) found no significant difference in vasodilatory activity among maxadilan variants derived from different Lu. longipalpis sibling species.
The objectives of this study were to determine if observed differences in the erythema-producing quality of saliva among Lu. longipalpis sibling species are due to differences in levels of messenger RNA (mRNA) expression of the maxadilan gene. This was examined by quantifying the amount of maxadilan mRNA present in salivary gland homogenates by quantitative reverse transcription polymerase chain reaction (Q-RT-PCR).
Results
The maxadilan gene contains an 84-bp intron starting at position 20 and terminating at position 103 (Fig. 1) . The length of the intron is sufficient to distinguish a maxadilan gene product amplified from genomic DNA from that amplified from cDNA when these are run on an agarose gel and stained with ethidium bromide (Fig. 2) . This allowed us to use the genomic maxadilan PCR product as the competitor in our competitive RT-PCR protocol.
The results of quantification of maxadilan mRNA from five colonies with different concentrations of competitor in agarose gels are shown in Fig. 3 and Table 1 . The curves in Fig. 3 were calculated from densitometric analyses of digital images of ethidium-stained agarose gels. These illustrate that amounts of competitor PCR product decrease with serial dilution and products of samples increase with decreasing amounts of competitor before reaching a plateau phase. Amounts of mRNA from Lapinha Cave flies are the highest (604.0 fg/per pair) and the amount from Brasilito, Costa Rica are the least (13.6 fg/per pair). There is a nearly forty-fivefold difference between the two. Competitor and sample DNA templates were amplified in single reactions using the A2 and 3′UT primers. PCR products were run on a 1.5% agarose gel stained with 0.3% ethidium bromide. The decreasing competitor concentration are 15 pg/ml (Lane 1), 7.5 pg/ml (Lane 2); 3.75 pg/ml (Lane 3), 1.88 pg/ml (Lane 4), 0.94 pg/ml (Lane 5), 0.47 pg/ml (Lane 6), 0.23 pg/ml (Lane7), 0.12 pg/ml (Lane 8). The graphs show curves of optical density vs. the concentration of cDNA in each lane. *The Lapinha Cave sample was diluted tenfold more than the other samples. (-ᮀ-sample; ᭝; competitor)
The within-strain variance in amounts of mRNA are small (SD = ± 0.21 to ± 0.60). Table 1 lists differences in the amounts of maxadilan mRNA, in femtograms per pair of salivary glands, for each of the five colonies studied. Colonies originating from South America have significantly more maxadilan mRNA than those from Costa Rica. The most significant difference is between the Lapinha Cave (Brazil) colony and Brasilito (Costa Rica) colony.
Discussion
The parasite, Le. chagasi causes two very different diseases in humans. Visceral leishmaniasis occurs when parasites move from the primary site of infection in the skin and parasitize reticuloendothelial cells of the spleen, liver, bone marrow and lymph glands. Infections with Le. chagasi are more commonly known to cause visceral disease and this is the only form reported from South America. Atypical cutaneous leishmaniasis caused by Le. chagasi infection has been described from Costa Rica, Honduras and Nicaragua (Zeledon et al. , 1989; Ponce et al. , 1991; Belli et al. , 1999) . This disease takes the form of small, papular, non-ulcerative skin lesions. The lesions may persist for years but apparently never lead to visceral disease. Where atypical cutaneous leishmaniasis has been reported the visceral form is also known to occur. Attempts at demonstrating genetic differences between Leishmania parasites isolated from cutaneous and visceral cases has failed (Zeledon et al. , 1989; Ponce et al. , 1991; Belli et al. , 1999) .
A potentially important difference between Le. chagasi transmission in South and in Central America is that the infections are transmitted by different sand fly species (Lanzaro et al. , 1993) . A high degree of divergence in the amino acid sequence of the salivary peptide maxadilan was found among the sibling species of Lu. longipalpis , however all variants were found to have equivalent vasodilatory activities (Lanzaro et al. , 1999) . It is not known if different forms of maxadilan differ in their immunomodulatory activities. However, it is well known that sand fly saliva can enhance leishmanial infections. When Leishmania parasites are injected into animals with sand fly saliva, the resulting lesion is larger and more persistent than lesions produced when parasites alone are injected (Titus & Ribeiro, 1988; Samuelson et al. , 1991; . Variation in the vasodilatory properties of the saliva from different species have been proposed as one factor contributing to observed differences in the clinical manifestations of Le. chagasi infections (Warburg et al. , 1994; Lanzaro & Warburg, 1995) .
In this report, we describe polymorphisms in the levels of maxadilan mRNA in the salivary glands in Lu. longipalpis sibling species from five sites throughout Latin America. Flies originating from Costa Rica differ significantly from flies of South American origin in the amount of maxadilan mRNA detected in their salivary glands. Competitive Q-RT-PCR revealed that flies from Lapinha Cave, Brazil, contain nearly forty-five times more maxadilan mRNA than flies from Brasilito, Costa Rica (Table 1) . These results corroborate earlier observations based on Western blot analysis and measurements of the size of erythemas on human skin (Warburg et al. , 1994) .
We are using mRNA abundance as a measure of gene expression, however there are several possible explanations for the observed differences in the abundance of maxadilan mRNA that are not strictly related to gene activity. It may be that there are multiple copies of the maxadilan gene, all of which are expressed, and that our observations reflect differences among the sibling species in copy number. Another possiblity is that different mRNAs have different stabilities so that only those with longer half-lives are detected. Further study of the mechanism(s) accounting for the differences in maxadilan mRNA abundance should provide insights into this issue.
The present report is the first to demonstrate quantitative differences of maxadilan mRNA in five sand fly colonies from Central and South America. Semiquantitative and quantitative determination of mRNA have been traditionally performed using methods such as Northern blot and dot blot (Glabinski et al. , 1995; Seguin et al. , 1995) . Table 1 . Concentrations of maxadilan mRNA measured by RT-PCR and amounts of maxadilan mRNA per pair of salivary glands for flies from five colonies. The concentration of maxadilan mRNA was measured from the RT-PCR product by comparison with the concentration of competitor (Fig. 3) . The amount of maxadilan mRNA per pair of salivary glands was calculated from the concentration of maxadilan mRNA by multiplying by twenty, because 1 µl of the 20 µl RT reaction was used in the PCR These procedures require at least 1 µ g total RNA (Zhang et al. , 1997) . However, in this experiment the total RNA from one pair for salivary glands was less than 0.1 µ g (data not shown). The application of the competitive Q-RT-PCR method we used makes it possible to detect small amount of mRNA as evidence of some gene expression.
To generate quantitative data, internal or external standards are frequently used that 'mimic' or closely imitate the target RNA species with respect to primer binding. Both RNA and DNA mimics have been used. The RNA standard approach was often considered more precise because it controls for variations in both the RT and PCR reactions (Wang et al. , 1989) . However, there are many disadvantages of the synthetic RNA standard approach (Babu et al. , 1993) . Moreover, preparation of internal standard templates as a competitor is time consuming and laborious work, although it is a reliable method for mRNA quantification (Borson et al. , 1998) . Typically internal competitors are constructed by deleting a fragment from the sample cDNA sequence and ligating it to itself (Santagati et al. , 1993; Boer & Ramamoorthy, 1997) . Using a PCR product for the gene of interest, amplified from a genomic DNA template, as a competitor in the competitive Q-RT-PCR method has not previously been reported. This approach avoids the complicated work of designing and producing competitors. It is therefore concluded that the competitive Q-RT-PCR with a genomic DNA-based competitor represents a rapid and very sensitive method for the quantification of low abundance mRNA, and is not associated with the potential hazards of using radioisotopes.
Experimental procedures
Dissection of salivary glands from sand flies Sand flies from five laboratory strains of Lu. longipalpis originating from: Lapinha Caves and Jacobina, Brazil; El Callejon, Colombia; and Liberia and Brasilito, Costa Rica were studied. Salivary glands were dissected from 24-to 48-h-old female flies. The dissection was performed by pulling the head and thorax apart with forceps, revealing a pair of salivary glands protruding through the foramen magnum. The glands were removed from the head capsule with a dissection needle and transferred to a fresh 1.5-ml tube using a microcapillary tube.
Extraction of RNA and reverse transcription One pair of salivary glands was placed in a 1.5-ml microcentrifuge tube containing 0.5 ml of RNA . Following the manufacturer's protocol, 0.1 ml of chloroform was added and the tube was centrifuged at 12 000 g for 15 min at 4 ° C. After centrifugation the mixture was incubated for 2-3 min at room temperature (RT). The aqueous phase was then transferred to a fresh tube containing 0.25 ml of isopropanol. The sample was incubated at RT for 5-10 min and then centrifuged at 12 000 g for 30 min at 4 ° C for RNA precipitation.
The supernatant was removed and the RNA pellet washed once by vortexing with 0.5 ml of 75% ethanol. RNA was re-pelleted by centrifugation at 7500 g for 5 min at 4 ° C. The supernatant was removed and the RNA was reverse transcribed using oligo-dT for priming of DNA synthesis in a 20-µ l reaction using the SuperScript Preamplification System (Gibco BRL, Cat. no. 18089 -011) for first strand cDNA Synthesis. The reaction mixture contained 13 µ l of DEPC-treated water, 1 µ l of oligo(dT), 2 µ l of 10 × synthesis buffer, 1 µ l of 10 m M dNTP mix, 2 µ l of 0.1 M DTT and 1 µ l of SuperScript II RT and was performed according to the manufacturer's protocol. Synthesized first strand cDNA was stored at -20 ° C until use.
Competitive method
The DNA standard used in all reactions as competitor for the RT-PCR was the maxadilan gene, PCR amplified from genomic DNA from El Callejon, Colombia laboratory colony flies. This PCR product was purified with the Wizard PCR Preps DNA Purification System (Promega Cat. No. A7170). Primers for the PCR amplification of maxadilan DNA were as described in Lanzaro et al. , 1999 (forward primer A2: 5 ′-CTT-GCC-GTG-TTT-GCC-TT-3′ and reverse primer 3UT: 5′-TTT-CGG-AAA-ATT-CGT-TAC-3′). The concentration of the DNA standard was measured spectrophotometrically.
The PCR reactions were performed in a volume of 30 µl containing: 1 µl of the first strand cDNA, competitor DNA, 0.3 µl; 10 mM dNTP, 0.3 µl; 10× PCR buffer, 3 µl; DNA Polymerase 0.3 unit; 50 mM A2 and 3UT primers, 0.3 µl each. The concentration of the competitor was diluted from 15 pg/ml to 0.117 pg/ml in twofold series in eight tubes per sample. The first strand cDNA sample of Lapinha Caves flies was diluted tenfold because the concentration of the sample was too high to analyse. Five individual samples (flies) from each colony were individually evaluated.
Conditions for the PCR were as follows: an initial denaturation at 94 °C for 5 min followed by twenty-five cycles of: 50 °C, 30 s; 72 °C, 30 s; 94 °C, 30 s and 72 °C, 7 min for extension. Ten microlitres of PCR product were analysed by electrophoresis in a 1.5% agarose gel containing 0.3 µg/ml ethidium bromide. Bands representing PCR products were visualized on an Eagle EyeII (Stratagene) apparatus under UV and the product quantified and analysed using the One-D Scan software package (Scanalytics, Fairfax, VA) . The concentration of sample cDNA was calculated from the concentration of competitor cDNA that generated equal amounts of competitor and sample product by applying the equation of Kotake et al. (1996) : log(T n /C n ) = log T 0 -log C 0 Where, T 0 = the initial amount of cDNA sample; T n = the final amount of cDNA sample over the number of PCR cycles (n); C 0 = the initial amount of competitor; C n = the final amount of competitor over the number of PCR cycles. Negative controls for all PCR produced no product detectable on ethidium-stained gels. Bands generated from RT products produced DNA fragments of a size consistent with the absence of sequence for the 84-bp intron, indicating no contamination with genomic DNA.
